Bellevue Group Ag Wave Life Sciences Ltd. Transaction History
Bellevue Group Ag
- $5.98 Billion
- Q2 2024
A detailed history of Bellevue Group Ag transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Bellevue Group Ag holds 4,094,458 shares of WVE stock, worth $34.8 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
4,094,458
Previous 4,094,458
-0.0%
Holding current value
$34.8 Million
Previous $25.3 Million
19.12%
% of portfolio
0.34%
Previous 0.4%
Shares
8 transactions
Others Institutions Holding WVE
# of Institutions
146Shares Held
93MCall Options Held
33KPut Options Held
57.2K-
Ra Capital Management, L.P. Boston, MA18.2MShares$155 Million1.37% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx7.67MShares$65.2 Million0.75% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$57.3 Million0.0% of portfolio
-
M28 Capital Management LP Stamford, CT6.16MShares$52.4 Million35.47% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.36MShares$45.5 Million0.05% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $738M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...